Lightnews — Scholar-powered news

Absea Biotech @abseabio.bsky.social · 3h

Papers & contact:

@natgenet.nature.com perspective: www.nature.com/articles/s41...

Molecular and Cellular Proteomics research: www.mcponline.org/article/S153....

Interested in using N15? [email protected]

A standardized framework for circulating blood proteomics - Nature Genetics

The field of blood proteomics faces an upsurge of data with the challenge of cross-study comparisons. This Perspective offers an in-depth analysis and proposes reference materials to enhance data integration and accelerate clinical translation.

www.nature.com

Absea Biotech @abseabio.bsky.social · 3h

1

Absea Biotech @abseabio.bsky.social · 3h

1

Absea Biotech @abseabio.bsky.social · 3h

New in @natgenet.nature.com: “A standardized framework for circulating blood proteomics” — co-authored by our SVP, Philip Lössl.
Recommends pooled plasma refs + isotope-labeled protein spike-ins.

Thoughts on adoption?

Learn more about👇

#Proteomics #15N #teammassspec

1

Absea Biotech @abseabio.bsky.social · 1d

Day 1 at the Westlake Symposium for AI Proteomics & Virtual Cell!

Philip Lössl (our SVP) already chaired a panel — excited to connect with peers and discuss AI-driven proteomics.

Attending? Reach out, we’d love to chat!

#Proteomics #LifeSciences #Ai #teammassspec

Absea Biotech @abseabio.bsky.social · 2d

Back-to-back proteomics in China.

After Westlake (Oct 8–10), Absea is heading to CNHUPO 2025 in Guangzhou (Oct 11–14).

Philip Lössl (SVP) & Joy Zhou (Marketing Dir.)will represent our team

Looking forward to connecting — DMs open for 1:1s!

#CNHUPO2025 #Proteomics #Biotech #Conference

1

Absea Biotech @abseabio.bsky.social · 7d

Source: European Centre for Disease Prevention and Control (12-month Chikungunya virus disease case notification rate per 100 000 population, September 2024-August 2025).

Absea Biotech @abseabio.bsky.social · 7d

ECDC: ~317,000 chikungunya cases in 2025 (Aug 2025).

Absea® Recombinant CHIKV E2 Protein (PQ-4086) is a reliable antigen standard that:
• Preserves E2 structure
• Supports assay specificity
• Speeds IVD development

Reach out for samples and technical info! 📩

#chikungunya #biotech #LifeSciences

1 2

Absea Biotech @abseabio.bsky.social · 9d

Heads up, #Proteomics Community! 📢

We're sending our team to the Westlake Symposium for AI Proteomics & Virtual Cell (Oct 8–9).

Participants include Tao Chen (CEO), Philip Lössl (SVP), and Joy Zhou (Marketing Dir.).

Here to exchange ideas and connect, DM us if you'd like to organise a 1:1!

2

Absea Biotech @abseabio.bsky.social · 14d

Summer’s wrapping up!

Our team swapped pipettes for plates and slides for stories across two September team days:
one exploring Schorfheide, another enjoying an evening picnic.

Plenty of catching up, some quick decisions, and now ready for autumn experiments!

#Teamwork #AutumnVibes

Absea Biotech @abseabio.bsky.social · 16d

Testing pan-allelic enrichment in AML PBMCs with Absea MB-081 beads.

✔️ matched competitors for peptide yield and neoantigen IDs
✔️ motifs remained stable
✔️ beads maintained performance after >12 months’ storage.

RUO.
Contact [email protected] or see datasheets on: www.absea.bio/product-deta...

Absea Biotech @abseabio.bsky.social · 20d

@natsmb.nature.com

Absea Biotech @abseabio.bsky.social · 21d

📢 New paper co-authored by our SAB member Bruce Stillman (cshlnews.bsky.social) in Nature SMB delves into how ORC, Cdc6, Cdt1 & MCM2-7 license DNA replication origins — tying structural and biochemical work to genome-stability implications.

Read more here: www.nature.com/articles/s41...

Mechanisms for licensing origins of DNA replication in eukaryotic cells - Nature Structural & Molecular Biology

Here, the authors comprehensively discuss the different mechanisms for origin licensing in yeast and human cells. Importantly, they present intuitive videos illustrating such mechanisms with unprecede...

www.nature.com

1 1

Absea Biotech @abseabio.bsky.social · 23d

For research use only. Not for diagnostic use.

👉 Contact us or visit our official page to learn more: www.absea.bio/index.html.

Absea-Absea Biotechnology Ltd.

Absea develops, engineers and characterizes protein and antibody reagents with unprecedented throughput and quality. We strive to provide products, services and tools to break new ground in protein re...

www.absea.bio

Absea Biotech @abseabio.bsky.social · 23d

How do you measure “N” in the AT(N) Alzheimer’s framework? t-tau? Too much from peripheral Big-tau.
NfL? Not AD-specific.

BD-tau offers a more specific blood readout. Absea’s new BD-Tau125 antibody pinpoints the exon 4–5 junction, detecting brain-derived tau with high specificity.

Details below 👇

1

Absea Biotech @abseabio.bsky.social · 28d

Our CEO, Tao Chen, will present “Synthetic and interaction proteomics for systems aging biology” at the Stem Cell, Aging, and Rejuvenation session — Cold Spring Harbor Asia.

🗓 Tue, Sept 16 — 19:00 CEST

Want to follow the session or connect afterward? DM us!

#proteomics #aging

1

Absea Biotech @abseabio.bsky.social · Sep 9

MTBR-tau243 — a disease-specific Alzheimer’s biomarker that tracks NFT burden.

Unlike some p-tau measures, it rises through disease stages. Absea’s mAbs (ELISA epitope mapping) enable sensitive CSF & plasma detection for staging, monitoring & trials.

Connect with us or visit: www.absea.bio !

Absea Biotech @abseabio.bsky.social · Sep 4

New in MCP: Absea’s ¹⁵N protein standards supported multi-peptide quantification in patient plasma (ALD panel).
LOQs per protein down to low attomole level, median CV ≈ 5.1% (normalized to heavy spike-in).

Read more here: www.mcponline.org/article/S153...

#Proteomics#MassSpec mannlab.bsky.social

A novel hybrid high speed mass spectrometer allows rapid translation from biomarker candidates to targeted clinical tests using 15N labeled proteins

Recent developments in affinity binder or mass spectrometry (MS)-based plasma proteomics are now producing panels of potential biomarker candidates for diagnosis or prognosis. However, clinical valida...

www.mcponline.org

1

Absea Biotech @abseabio.bsky.social · Sep 2

Learn more: www.absea.bio/asms2025.html

#Alzheimer #Biomarkers #Neuroscience #Antibodies

Absea-Absea Biotechnology Ltd.

Absea develops, engineers and characterizes protein and antibody reagents with unprecedented throughput and quality. We strive to provide products, services and tools to break new ground in protein re...

www.absea.bio

1

Absea Biotech @abseabio.bsky.social · Sep 2

For Tau research, breadth and specificity matter.

Absea's antibody toolkit targets >50 site-specific pTau isoforms (not just p-Tau181/217 but rare ones like p-Tau205), all with mapped epitopes and assay validation.

A comprehensive resource for reliable results.
Let’s get in touch!

1

Absea Biotech @abseabio.bsky.social · Aug 28

Ever pieced together three kits just to hit five targets? 😓.
Now imagine a single kit where you pick:
• Five validated #antibodies (10 µL each)
• One or two free 100 µL secondary antibodies
That’s our brand new Pick 5‑ #AntibodyKit —one kit, no extra orders.
Connect with us to get started!

Absea Biotech @abseabio.bsky.social · Aug 26

🔗 Explore our full catalogue: www.absea.bio/index.html

Absea-Absea Biotechnology Ltd.

Absea develops, engineers and characterizes protein and antibody reagents with unprecedented throughput and quality. We strive to provide products, services and tools to break new ground in protein re...

www.absea.bio

Absea Biotech @abseabio.bsky.social · Aug 26

Trouble with IP?

Absea’s anti-Myc/HA/FLAG magnetic beads are IP-verified and show strong signal, low background, and stable performance across tags and elution modes.

Happy to share protocols or tips—let’s connect!

#ProteinResearch #LifeScience

1

Absea Biotech @abseabio.bsky.social · Aug 22

Super well derserved! Massive congratulations, Misha!

1

Absea Biotech @abseabio.bsky.social · Aug 21

Speakers: Matthias @mannlab.bsky.social (@mpibiochem.bsky.social) Mikhail @savitski-lab.bsky.social (embl.org), Philip Lössl (Absea'SVP)